Zocon L Cream contains Luliconazole 1% w/w, a broad-spectrum antifungal agent belonging to the imidazole class, indicated for the topical treatment of various superficial fungal infections. Luliconazole exhibits potent fungicidal activity against dermatophytes, yeasts, and molds by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Zocon L Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, tinea pedis, and candidal infections of the skin. The cream formulation ensures effective penetration into the stratum corneum, facilitating rapid symptom relief and resolution of infection. It is typically applied once daily to the affected area and surrounding skin after cleansing and drying, with treatment duration varying based on the infection type and severity, generally ranging from 1 to 4 weeks. Zocon L Cream is well-tolerated, with minimal adverse effects; however, mild local reactions such as burning, itching, or erythema may occur. It is contraindicated in patients with known hypersensitivity to luliconazole or any cream excipients. Caution is advised when used on extensive areas or broken skin. As with all topical antifungals, adherence to the prescribed regimen is essential to prevent recurrence and resistance.